Related Experiment Video
Updated: May 29, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Unravelling the complexity of metastasis - molecular understanding and targeted therapies
1Department of Molecular Biology, Washington Road, LTL 255, Princeton University, Princeton, New Jersey 08544, USA.
Abstract:
Despite recognizing the devastating consequences of metastasis, we are not yet able to effectively treat cancer that has spread to vital organs. The inherent complexity of genomic alterations in late-stage cancers, coupled with numerous heterotypic interactions that occur between tumour and stromal cells, represent fundamental challenges in our quest to understand and control metastatic disease. The incorporation of genomic and other systems level approaches, as well as technological breakthroughs in imaging and animal modelling, have galvanized the effort to overcome gaps in our understanding of metastasis. Future research carries with it the potential to translate the wealth of new knowledge and conceptual advances into effective targeted therapies.
Insights
Effective treatments for metastatic cancer remain elusive due to complex genomic changes and tumor-stromal interactions. New genomic and imaging technologies offer hope for understanding and targeting cancer spread to improve patient outcomes.
Area of Science:
- Oncology
- Genomics
- Cancer Biology
Background:
- Metastasis, the spread of cancer, has devastating consequences but lacks effective treatments.
- Late-stage cancers present complex genomic alterations and interactions between tumor and stromal cells, hindering understanding and control.
- Current therapeutic strategies are insufficient for managing widespread metastatic disease.
Purpose of the Study:
- To address the challenges in understanding and controlling metastatic cancer.
- To explore how genomic and systems-level approaches can advance metastasis research.
- To identify potential pathways for translating new knowledge into effective targeted therapies.
Main Methods:
- Integration of genomic and systems-level analyses.
- Application of advanced imaging technologies.
- Utilization of innovative animal models for studying metastasis.
Main Results:
- Genomic and systems-level approaches are galvanizing research into metastasis.
- Technological breakthroughs in imaging and animal modeling are enhancing our understanding.
- Significant progress is being made in overcoming knowledge gaps in metastatic disease.
Conclusions:
- Despite challenges, advancements in technology and research approaches are improving our understanding of cancer metastasis.
- Future research holds promise for developing novel targeted therapies to combat metastatic cancer.
- Translating new knowledge into effective treatments is a key goal for improving patient outcomes in advanced cancers.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway

